Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to announce the winner of their Cancer Discovery Incubator Award, Midissia Therapeutics (Midissia). Midissia is a clinical stage immunotherapy start-up focused on immune intensification.
{iframe}http://www.businesswire.com/news/home/20170421005014/en/Immunomic-Therapeutics-Announces-Winner-Cancer-Discovery-Incubator{/iframe}